Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
4736.TW
STRONG BUYREMOVETaiDoc Technology Corporation · Healthcare · Taiwan · $368M · Avg Vol: $670K/d
Medical device manufacturer with solid quality metrics but lacking a clear connection to our high-conviction macro themes.
COMPANY DESCRIPTION
TaiDoc Technology Corporation designs and manufactures medical devices, primarily blood glucose monitoring systems, nebulizers, and multi-parameter monitors. The company operates as one of the largest medical device OEMs/ODMs in Taiwan, leveraging proprietary biosensor technology and automated production lines. It is a leading medical device manufacturer with a strong global footprint in both private label and branded healthcare markets.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 304.2M | 151.9M | 146.6M | 132.8M | -24.1% |
| EPS | 0.67 | 1.14 | 0.34 | 0.38 | — | -17.1% |
| Shares | — | 95.2M | 95.4M | 95.4M | 95.4M | +0.1% |
| Debt | — | 20.1M | 34.5M | 33.3M | 36.7M | 22.2% |
| Equity | — | 305.5M | 281.2M | 287.1M | 309.2M | 0.4% |
| Op CF | — | 101.4M | 37.0M | 30.8M | 27.0M | -35.7% |
| Inv CF | — | -18.1M | 4.1M | -38.2M | -9.4M | — |
| Fin CF | — | -55.9M | -46.2M | -30.9M | -28.3M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 4736.TW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 4736.TW | TaiDoc Technology Corporation(you) | $368M | 91 | STRONG BUY |
| 6861.TW | InnoCare Optoelectronics Corporation | $497M | 72 | BUY |
| 4106.TW | Wellell Inc. | $74M | 91 | STRONG BUY |
| 4129.TWO | United Orthopedic Corporation | $275M | 64 | HOLD |
| 6918.TW | A Plus Biotechnology Co., Ltd. | $80M | 74 | BUY |
| 4155.TW | OK Biotech Co., Ltd. | $67M | 66 | BUY |
| 4771.TW | Vizionfocus Inc. | $357M | 87 | STRONG BUY |
| 1720.TW | Standard Chemical & Pharmaceutical Co., Ltd. | $353M | 97 | STRONG BUY |
| 3705.TW | YungShin Global Holding Corporation | $481M | 90 | STRONG BUY |
| 1707.TW | Grape King Bio Ltd | $462M | 95 | STRONG BUY |
Peer medians: ROE 3.4% · P/E 16.4x · Gross margin 42.1%